Table 2 Primary assessments of the ASSURE-CSU study
Medical record data | Patient-reported data |
|---|---|
Demographic characteristics | Impact of disease tools: |
• EQ-5D-3L | |
• DLQI | |
• CU-Q2oL | |
• AE-QoL (in patients with angioedema) | |
Baseline medical history | Angioedema history and characterization |
Treatment received for CSU/CIU | Healthcare resource utilization (other than that recorded in charts, use of alternative medications and out-of-pocket expenses) |
Duration of treatments | Disease activity (UAS7) |
Total healthcare resource utilization | Work days and productivity loss (WPAI-SHP) |